Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
IB Acquisition Corp.
SIC 8731 · Services-Commercial Physical & Biological Research
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
IB Acquisition Corp.
SIC 8731 · Services-Commercial Physical & Biological Research
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
IB Acquisition Corp.
SIC 8731 · Services-Commercial Physical & Biological Research
Notes
Support
about
terms
$
IBACR
IB Acquisition Corp.
CIK:
0001998781
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
General and administrative expenses
$ 624,429
$ 172,210
$ 1,552,606
$ 512,136
Loss from operations
(624,429)
(172,210)
(1,552,606)
(512,136)
Other income:
Interest and dividends earned on cash and investments held in Trust Account
72,485
1,254,202
362,876
3,875,873
Other income
72,485
1,254,202
362,876
3,875,873
(Loss) income before provision for income taxes
(551,944)
1,081,992
(1,189,730)
3,363,737
Provision for income taxes
(15,222)
(263,382)
(76,204)
(813,933)
Net (loss) income
$ (567,166)
$ 818,610
$ (1,265,934)
$ 2,549,804
Redeemable Common Stock [Member]
Other income:
Basic weighted average common stock outstanding, non-redeemable
759,139
11,500,000
1,230,884
11,500,000
Diluted weighted average common stock outstanding, non-redeemable
759,139
11,500,000
1,230,884
11,500,000
Basic net (loss) income per common stock, non-redeemable
$ (0.11)
$ 0.05
$ (0.23)
$ 0.16
Diluted net (loss) income per common stock, non-redeemable
$ (0.11)
$ 0.05
$ (0.23)
$ 0.16
Non-redeemable Common Stock [Member]
Other income:
Basic weighted average common stock outstanding, non-redeemable
4,249,090
4,249,090
4,249,090
4,249,090
Diluted weighted average common stock outstanding, non-redeemable
4,249,090
4,249,090
4,249,090
4,249,090
Basic net (loss) income per common stock, non-redeemable
$ (0.11)
$ 0.05
$ (0.23)
$ 0.16
Diluted net (loss) income per common stock, non-redeemable
$ (0.11)
$ 0.05
$ (0.23)
$ 0.16
v3.26.1
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:
Net (loss) income
$ (1,265,934)
$ 2,549,804
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest and dividends earned on cash and investments held in Trust Account
(362,876)
(3,875,873)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
(22,169)
(16,116)
Short-term prepaid insurance
(55,122)
254,625
Prepaid income taxes
(121,250)
Due to Sponsor
2,788
Accounts payable and accrued expenses
428,701
(65,942)
Excise taxes payable
301,991
Income taxes payable
(694,245)
(110,067)
Net cash used in operating activities
(1,790,904)
(1,260,781)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account to pay income taxes
105,000
924,000
Cash withdrawn from Trust Account in connection with redemption
7,886,591
Net cash provided by investing activities
7,991,591
924,000
Cash Flows from Financing Activities:
Proceeds from promissory note – related party
500,000
Proceeds from promissory note
292,344
Repayment of promissory note
(292,344)
Redemptions of Common Stock
(7,886,591)
Net cash used in financing activities
(7,386,591)
Net Change in Cash and Restricted Cash
(1,185,904)
(336,781)
Cash and cash equivalents and Restricted Cash – Beginning of period
1,216,065
822,799
Cash and Restricted Cash – End of period
30,161
486,018
Cash
30,161
486,018
Cash – restricted
Non-Cash investing and financing activities:
Remeasurement of Common Stock subject to possible redemption
286,005
3,061,940
Excise tax payable attributable to redemption of Common Stock
$ 78,866
v3.26.1
Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Sep. 30, 2025
Current assets
Cash
$ 30,161
$ 428,700
Cash – restricted
787,365
Prepaid expenses and other current assets
50,002
27,833
Short-term prepaid insurance
55,122
Prepaid income taxes
121,250
Total current assets
256,535
1,243,898
Cash and investments held in Trust Account
8,261,479
15,890,194
Total Assets
8,518,014
17,134,092
Current liabilities
Accounts payable and accrued expenses
502,458
73,757
Income taxes payable
694,245
Excise taxes payable
1,442,167
1,061,310
Promissory note – related party
500,000
Due to Sponsor
2,788
2,788
Total Liabilities
2,447,413
1,832,100
Commitments and contingencies (Note 6)
Common stock subject to possible redemption, 759,139 and 1,490,880 shares at redemption value of $11.04 and 10.72 per share as of June 30, 2026 and September 30, 2025, respectively
8,382,729
15,983,315
Stockholders’ Deficit
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and September 30, 2025
Common stock, $0.0001 par value, 100,000,000 shares authorized, 4,249,090 shares issued and outstanding as of June 30, 2026 and September 30, 2025
425
425
Additional paid-in capital
Accumulated Deficit
(2,312,553)
(681,748)
Total Stockholders’ Deficit
(2,312,128)
(681,323)
Total Liabilities and Stockholders’ Deficit
$ 8,518,014
$ 17,134,092